4-Methoxy-3-methylphenylacetic acid, 98.0%, 100mg

benzyl 2-oxo-1,7-diazaspiro[3.5]nonane-7-carboxylate, 97%, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)pyridine, 95+%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-fluoro-1H-indol-3-yl)propanoic acid, 98%, 10g

2-Chloro-6-methylpyridine-4-carbaldehyde, 95+%, 2.5g

2-Amino-6-methyl-5-nitropyridine, 97.0%, 100g

(2E)-3-(5-methylfuran-2-yl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

Ethyl 2-Methylnicotinate>98.0%(GC)(T)25g

2-Bromo-3,4-dimethyl-6-nitroaniline, 97.0%, 5g

tert-Butyl 4-acryloylpiperazine-1-carboxylate, 95+%, 100mg

Spiro[2.4]heptan-5-ol, 98%, 1g

2-Hydroxy-4-methylbenzamide, 95.0%, 5g